grid-line

ImmunityBio

This clinical-stage biotechnology company, a subsidiary of NantWorks LLC, is primarily engaged in the development of therapies for cancer and infectious diseases. Its research and development efforts are aimed at harnessing the power of the immune system to fight disease, with a particular focus on hard-to-treat cancers and chronic viral infections.
27.1K
Volume
+8400%
Growth
regular